Medical Technologies International

Medical Technologies International, Inc. provides non-invasive diagnostic products and support services for the early detection and monitoring of atherosclerotic vascular diseases. The company focuses on developing solutions that aid in the detection and treatment of heart disease and stroke. Its main product, ArterioVision, includes a standardized B-mode ultrasound image acquisition method and software, enabling clinicians to safely and non-invasively screen and monitor atherosclerosis in patients with or without symptoms of cardiovascular disease. It offers non-invasive diagnostic products and support services to the global medical community for the early detection and monitoring of atherosclerotic vascular diseases, which are the leading cause of morbidity and mortality in China. This is achieved through the use of proprietary ultrasound image processing software and scientific methods developed by the Atherosclerosis Research Unit (ARU) at Caltech and the Keck School of Medicine of USC. In addition to its proprietary patented products, MTI also holds an exclusive global license with Caltech and USC.